[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346235-105":59,"doc-detail-346235-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-a-prognostic-model-based-on-t-cell-signature-genes-in-colon-cancer-abstract","Development and validation of a prognostic model based on T cell signature genes in colon cancer - Abstract","","Colon cancer (CC) is a highly prevalent malignancy worldwide, yet the specific molecular roles of T cells in tumor microenvironment (TME)–driven progression remain incompletely defined. The study used TCGA-COAD transcriptomic data for differential expression, then identified T cell signature genes via single-cell RNA sequencing (scRNA-seq). Candidate prognostic genes were selected with LASSO regression and multivariate Cox models, forming a seven-gene risk prognostic model. ROC and external GEO validation supported consistent predictive performance, and the signature genes suggest potential therapeutic targets to support clinical decision-making.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-a-prognostic-model-based-on-t-cell-signature-genes-in-colon-cancer-abstract/346235/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-a-prognostic-model-based-on-t-cell-signature-genes-in-colon-cancer-abstract/346235.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were T cell signature genes identified for the prognostic model?","Question",{"text":112,"@type":113},"The work analyzed TCGA-COAD transcriptomic data for differential expression and used single-cell RNA sequencing (scRNA-seq) to identify T cell signature genes, followed by intersectional and prognostic gene screening.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which methods were used to build the prognostic model?",{"text":117,"@type":113},"Least absolute shrinkage and selection operator (LASSO) regression was used for gene screening, and a multivariate Cox proportional hazards model constructed the prognostic model.",{"name":119,"@type":110,"acceptedAnswer":120},"How was the model performance evaluated?",{"text":121,"@type":113},"Receiver operating characteristic (ROC) curves assessed predictive performance, and participants were stratified into high- and low-risk cohorts by risk score. External validation was performed using three GEO datasets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346235,1790785267,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Clinical and Experimental Medicine (2026) 26:69  \n[https://doi.org/10.1007/s10238-025-01994-4](https://doi.org/10.1007/s10238-025-01994-4)  \nRESEARCH  \nDevelopment and validation of a prognostic model based onT cell signature genes in colon cancer using single-cell RNA sequencing  \nPeijue Wang1 · Yongxiang Li1  \nReceived: 7 July 2025 / Accepted: 29 November 2025 © The Author(s) 2025  \nAbstract  \nColon cancer (CC) stands as one of the most prevalent malignant neoplasms worldwide. Despite extensive investigationson the function of T cells in antitumor immunity and dynamics of tumor microenvironment (TME), their precise molecular contributions to the CC progression remain incompletely characterized. Differential gene expression analysis was implemented leveraging TCGA-COAD transcriptomic data, followed by the identification of T cell signature genes using single-cell RNA sequencing (scRNA-seq) dataset. Through intersectional analysis and subsequent prognosis-related gene screening using least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox proportional hazards models, a prognostic model was established. Moreover, its performance was evaluated via receiver operating characteristic (ROC) curves. Participants were split into high-risk and low-risk cohorts based on risk scores, to explore potential immunological differences between groups. A prognostic model was developed based on seven genes, encompassing UBE2N, TUBA1C, FXR1, CBLB, YTHDC1, GPRIN3, and AGPAT2 . The area under the ROC curve (AUC) for the training cohort at 3, 5, and 7 years reached 0.676, 0.715, and 0.721, respectively. External validation using three GEO datasets demonstrated consistent predictive performance of the model. The AUC values at 3, 5, and 7 years were 0.632, 0.617, and 0.582 in GSE39582, 0.689, 0.755, and 0.951 in GSE17537, and 0.667, 0.653, and 0.649 in GSE161158 . The identified T cell signature genes may function as potential therapeutic targets, while the developed prognostic model and nomogram may facilitate clinical decision-making for CC management.  \nKeywords Colon cancer · T cells · Single-cell RNA sequencing · Prognosis · Immune microenvironment  \nBackground  \nColorectal cancer (CRC) represents one of the most prevalent malignancies around the world [1] . According to the Global Cancer Statistics 2025, CRC, including colon cancer (CC) and rectal cancer (RC) constitutes approximately 9.6% of all newly diagnosed cancers. It stands as the third most prevalent kind of cancer in incidence and the second primary contributor to death linked to cancer (9.3%) globally [2] . In China, a high-burden country for CRC, there were 555,000 new diagnoses and 286,000 deaths in 2020. The incidence and mortality rates of CRC are 29.44/100,000  \n􀀍 Yongxiang Li[liyongxiang@ahmu.edu.cn](liyongxiang@ahmu.edu.cn)  \n1 General Surgery Department, The First Affiliated Hospital of Anhui Medical University, Jixi Road, Shushan District, Hefei 230032, Anhui, China  \nand 14.23/100,000, respectively, ranking second and fifth among all cancers nationwide [3] . Colon adenocarcinoma (COAD), the predominant histological subtype of CRC, is intrinsically linked to the immunosuppressive features of TME. Notably, recent epidemiological trends reveal an alarming rise in the incidence of COAD among individuals under the age of 65, potentially due to lifestyle changes such as obesity and high-fat diets [4] . Despite the promising outcomes of immune checkpoint inhibitors (ICIs) like PD-1/ PD-L1 inhibitors in microsatellite instability-high (MSI-H) CRC [5, 6], they are largely ineffective in microsatellitestable (MSS) COAD, which comprises 80–90% of cases, with response rates below 10%[7] . This highlights the complexity of molecular heterogeneity and immune suppression within the TME, thereby underscoring the potential value of identifying novel therapeutic targets and strategies.  \nTME comprises various immune and inflammatory cells, cancer-related fibrobl","cbCaiqhxUly1lvqA","https://ap.wps.com/l/cbCaiqhxUly1lvqA","pdf",9627477,"English","# Abstract\n## Background\n## TME and immune suppression in colon cancer","[{\"question\":\"How were T cell signature genes identified for the prognostic model?\",\"answer\":\"The work analyzed TCGA-COAD transcriptomic data for differential expression and used single-cell RNA sequencing (scRNA-seq) to identify T cell signature genes, followed by intersectional and prognostic gene screening.\"},{\"question\":\"Which methods were used to build the prognostic model?\",\"answer\":\"Least absolute shrinkage and selection operator (LASSO) regression was used for gene screening, and a multivariate Cox proportional hazards model constructed the prognostic model.\"},{\"question\":\"How was the model performance evaluated?\",\"answer\":\"Receiver operating characteristic (ROC) curves assessed predictive performance, and participants were stratified into high- and low-risk cohorts by risk score. External validation was performed using three GEO datasets.\"}]","Development and validation of a prognostic model based on T cell signature genes in colon cancer - Abstract | PDF",1790060578,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8754e805fd6faabe7ceef8034e31ff36.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a22a3b9bcc46468d9a2d850f0ed1150.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dd5ef14f5a426e00e096c3e83faa4cf.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a288b76bca41686cedf2f55db85bdd27.webp",980,1301]